Fire At Serum Institute Won't Disrupt AZ-Oxford COVID-19 Vaccine Supplies
Vaccine Diplomacy Undeterred
Executive Summary
Set to provide a COVID-19 vaccine partnered with AstraZeneca/Oxford to COVAX and various governments from Brazil to South Africa, India's Serum Institute assures that a fire at one of its units under construction will not impact supplies.
You may also be interested in...
Biocon Biologics And Serum Institute Join Forces
Serum to hold 15% in Biocon arm Biocon Biologics as part of a broad alliance that expects to leverage the partners' strengths and resources in vaccines and biologics. Pursuing opportunities based on the hot mRNA technology platform appears firmly on the table.
Biocon-Serum Combine Forces, mRNA Opportunities On Radar
Serum to hold 15% in Biocon arm Biocon Biologics as part of a broad alliance that expects to leverage the partners' strengths and resources in vaccines and biologics. Pursuing opportunities based on the hot mRNA technology platform appears firmly on the table.
Will AZ Legal Notice, Clotting Incidents Cloud Serum’s Fortunes?
AstraZeneca has sent a legal notice to Indian partner Serum Institute for non-delivery of COVID-19 vaccines. Will this and the entry of a new challenger, Sputnik V, in the Indian market affect Serum’s fortunes? Will the EMA and MHRA announcement on clotting incidents related to the AZ vaccine shrink demand for the partnered vaccine?